2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year’s report includes some new analyses, which quantify the cancer-related health services and policy research (HSPR) investment for the five-year period, 2014-2018. The investment in cancer-related HSPR represented 5% of the overall cancer research investment for this period, with a fairly stable annual amount of between $26M to $27M.
The report has an accompanying slide deck and Excel file that expand on the report analyses. To access the annual report and companion documents, click here.
Recommendations for Cancer-related Health Services and Policy Research
CCRA has published a series of recommendations on cancer-related health services and policy research, which reflect consultations held during 2020-21 led by Dr. Terry Sullivan. We are indebted to the many experts w... Read More »
CCRA has published a series of recommendations on cancer-related health services and policy research, which reflect consultations held during 2020-21 led by Dr. Terry Sullivan. We are indebted to the many experts w... Read More »
CanPath Webinar: How Population Cohorts Can Support COVID-19 Research
CanPath, in partnership with the University of Toronto’s Dalla Lana School of Public Health, will provide a webinar on Wednesday June 24th (Noon to 1:00 pm EDT) on how large population cohorts can respond in a pandemic and support rapid national research efforts. The webinar will featur... Read More »
CanPath, in partnership with the University of Toronto’s Dalla Lana School of Public Health, will provide a webinar on Wednesday June 24th (Noon to 1:00 pm EDT) on how large population cohorts can respond in a pandemic and support rapid national research efforts. The webinar will featur... Read More »